Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM.
Riedinger CJ, et al.
Gynecol Oncol. 2024 Mar 29;183:78-84. doi: 10.1016/j.ygyno.2024.03.020. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38554477
Free article.